- $146.62bn
- $143.23bn
- $8.97bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,460 | 4,519 | 5,896 | 7,245 | 8,971 |
Cost of Revenue | |||||
Gross Profit | 2,664 | 3,532 | 4,543 | 5,672 | 7,050 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,418 | 4,367 | 5,642 | 6,890 | 8,209 |
Operating Profit | 42.1 | 152 | 254 | 355 | 762 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 67.2 | 149 | 249 | 399 | 1,008 |
Provision for Income Taxes | |||||
Net Income After Taxes | 627 | 119 | 230 | 325 | 1,731 |
Net Income Before Extraordinary Items | |||||
Net Income | 627 | 119 | 230 | 325 | 1,731 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 627 | 119 | 230 | 325 | 1,731 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.18 | 0.768 | 1.15 | 1.6 | 8.42 |